LECANEMAB AUTOINJECTOR 200 mg/mL
lecanemab-irmb · INJECTION, SOLUTION · Eisai Inc.
LECANEMAB AUTOINJECTOR is a injection, solution containing lecanemab-irmb at 200 mg/mL, taken subcutaneous. Manufactured by Eisai Inc..
Key Facts
- Brand Name
- LECANEMAB AUTOINJECTOR
- Generic Name
- lecanemab-irmb
- NDC Code (Product)
62856-220- Manufacturer
- Eisai Inc.
- Strength
- 200 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761375
- Drug Class
- Amyloid Beta-directed Antibody [EPC]
- Marketing Start
- 08/29/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is LECANEMAB AUTOINJECTOR used for?
LECANEMAB AUTOINJECTOR contains lecanemab-irmb. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is LECANEMAB AUTOINJECTOR a controlled substance?
LECANEMAB AUTOINJECTOR is not classified as a controlled substance by the DEA.
What is the generic name for LECANEMAB AUTOINJECTOR?
The generic name for LECANEMAB AUTOINJECTOR is lecanemab-irmb. There are no other listed brand versions of lecanemab-irmb.
What is the NDC code for LECANEMAB AUTOINJECTOR 200 mg/mL?
The NDC (National Drug Code) for LECANEMAB AUTOINJECTOR 200 mg/mL is 62856-220, listed by Eisai Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)